You Weon-Kyoo, Choi Won-Seok, Koh You-Seok, Shin Hang-Cheol, Jang Yangsoo, Chung Kwang-Hoe
R&D Center, Biobud Co. Ltd., Seoul 120-110, Republic of Korea.
FEBS Lett. 2004 Jul 30;571(1-3):67-73. doi: 10.1016/j.febslet.2004.06.060.
A thrombin-like enzyme of Bothrops atrox moojeni venom, batroxobin, specifically cleaves fibrinogen alpha chain, resulting in the formation of non-crosslinked fibrin clots. The cDNA encoding batroxobin was cloned, expressed in Pichia pastoris and the molecular function of purified recombinant protein was also characterized. The recombinant batroxobin had an apparent molecular weight of 33 kDa by SDS-PAGE analysis and biochemical activities similar to those of native batroxobin. The purified recombinant protein strongly converted fibrinogen into fibrin clot in vitro, and shortened bleeding time and whole blood coagulation time in vivo. However, it did not make any considerable alterations on other blood coagulation factors. Several lines of experimental evidence in this study suggest that the recombinant batroxobin is a potent pro-coagulant agent.
矛头蝮蛇穆氏亚种毒液中的一种类凝血酶——巴曲酶,能特异性切割纤维蛋白原α链,导致形成非交联纤维蛋白凝块。编码巴曲酶的cDNA被克隆出来,在毕赤酵母中表达,并且对纯化的重组蛋白的分子功能也进行了表征。通过SDS-PAGE分析,重组巴曲酶的表观分子量为33 kDa,其生化活性与天然巴曲酶相似。纯化的重组蛋白在体外能强烈地将纤维蛋白原转化为纤维蛋白凝块,在体内能缩短出血时间和全血凝固时间。然而,它对其他凝血因子没有产生任何显著改变。本研究中的几条实验证据表明,重组巴曲酶是一种有效的促凝血剂。